KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationEBIATLong-Term Debt IssuancesLong-Term Debt RepaymentsMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Shares IssuedShares RepurchasedShort-Term Debt issuances
Ratios

Abbott Laboratories (ABT) EBIAT (2016 - 2025)

Historic EBIAT for Abbott Laboratories (ABT) over the last 17 years, with Q3 2025 value amounting to $1.6 billion.

  • Abbott Laboratories' EBIAT fell 12.15% to $1.6 billion in Q3 2025 from the same period last year, while for Sep 2025 it was $14.0 billion, marking a year-over-year increase of 14236.17%. This contributed to the annual value of $13.4 billion for FY2024, which is 13417.79% up from last year.
  • According to the latest figures from Q3 2025, Abbott Laboratories' EBIAT is $1.6 billion, which was down 12.15% from $1.8 billion recorded in Q2 2025.
  • Abbott Laboratories' EBIAT's 5-year high stood at $9.2 billion during Q4 2024, with a 5-year trough of $1.0 billion in Q4 2022.
  • Over the past 5 years, Abbott Laboratories' median EBIAT value was $1.6 billion (recorded in 2023), while the average stood at $2.0 billion.
  • Per our database at Business Quant, Abbott Laboratories' EBIAT plummeted by 4806.44% in 2022 and then surged by 47898.37% in 2024.
  • Over the past 5 years, Abbott Laboratories' EBIAT (Quarter) stood at $2.0 billion in 2021, then tumbled by 48.06% to $1.0 billion in 2022, then soared by 54.31% to $1.6 billion in 2023, then soared by 478.98% to $9.2 billion in 2024, then tumbled by 82.19% to $1.6 billion in 2025.
  • Its last three reported values are $1.6 billion in Q3 2025, $1.8 billion for Q2 2025, and $1.3 billion during Q1 2025.